Bellevue Funds (Lux) Bellevue Obesity Solutions I Fonds
426,89
CHF
-2,87
CHF
-0,67
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 8,79% |
| UnitedHealth Group Inc | US91324P1021 | 6,91% |
| Novo Nordisk AS Class B | DK0062498333 | 5,74% |
| Johnson & Johnson | US4781601046 | 5,05% |
| Amgen Inc | US0311621009 | 3,37% |
| Thermo Fisher Scientific Inc | US8835561023 | 3,34% |
| Intuitive Surgical Inc | US46120E6023 | 3,34% |
| AstraZeneca PLC ADR | US0463531089 | 3,13% |
| Boston Scientific Corp | US1011371077 | 3,11% |
| Roche Holding AG | CH0012032048 | 2,88% |
| Sonstige | 54,35% |